Remicade (infliximab) - J&J
relatlimab (BMS-986016) - BMS
Opdivo (nivolumab) - Ono Pharma, BMS
Avsola (infliximab-axxq) - Amgen
Keytruda (pembrolizumab) - Merck (MSD)
Renflexis (infliximab-abda) - Yuhan Corp, Biogen, Ewopharma, Samsung, Organon
http://clinicaltrials.gov/ct2/show/NCT05034536
 
Aug 20, 2025
 
Next